Supernus Pharmaceuticals, Inc.

CAPTRUST FINANCIAL ADVISORS SUPN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

18,603

Value ($000)

925

Weight

0.0%

2020 Q2 - 2025 Q4 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	925	0.0%	18,603	12/31/2025
2025 Q3	11/19/2025	880	0.0%	18,415	9/30/2025
2025 Q2	8/15/2025	643	0.0%	20,412	6/30/2025
2025 Q1	5/15/2025	581	0.0%	17,731	3/31/2025
2024 Q4	2/14/2025	629	0.0%	17,394	12/31/2024
2024 Q3	11/14/2024	294	0.0%	9,425	9/30/2024
2024 Q2	8/15/2024	274	0.0%	10,244	6/30/2024
2024 Q1	5/15/2024	352	0.0%	10,331	3/31/2024
2023 Q4	2/14/2024	256	0.0%	8,857	12/31/2023
2023 Q3	11/15/2023	286	0.0%	10,359	9/30/2023
2023 Q1	5/15/2023	226	0.0%	6,250	3/31/2023
2022 Q4	2/15/2023	215	0.0%	6,041	12/31/2022
2022 Q3	11/16/2022	200	0.0%	5,914	9/30/2022
2022 Q2	8/23/2022	93	0.0%	3,204	6/30/2022
2022 Q1	5/16/2022	96	0.0%	2,983	3/31/2022
2021 Q4	2/14/2022	33	0.0%	1,133	12/31/2021
2021 Q3	11/16/2021	28	0.0%	1,042	9/30/2021
2021 Q2	8/16/2021	28	0.0%	896	6/30/2021
2021 Q1	5/17/2021	24	0.0%	916	3/31/2021
2020 Q4	2/16/2021	7	0.0%	275	12/31/2020
2020 Q3	11/17/2020	5	0.0%	225	9/30/2020
2020 Q2	8/14/2020	4	0.0%	175	6/30/2020